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Abstract
Background: Neurodevelopment requires thyroid hormone, yet the mechanisms and targets of
thyroid hormone action during embryonic stages remain ill-defined. We previously showed that the
thyroid hormone thyroxine (T4) rapidly increases voltage-gated sodium current in zebrafish
Rohon-Beard cells (RBs), a primary sensory neuron subtype present during embryonic
development. Here, we determined essential components of the rapid T4 signaling pathway by
identifying the involved intracellular messengers, the targeted sodium channel isotype, and the
spatial and temporal expression pattern of the nongenomic V3 integrin T4 receptor.
Results: We first tested which signaling pathways mediate T4's rapid modulation of sodium
current (INa) by perturbing specific pathways associated with nongenomic thyroid hormone
signaling. We found that pharmacological blockade of protein phosphatase 1 and the mitogen-
activated protein kinase p38 isoform decreased and increased tonic sodium current amplitudes,
respectively, and blockade of either occluded rapid responses to acute T4 application. We next
tested for the ion channel target of rapid T4 signaling via morpholino knock-down of specific
sodium channel isotypes. We found that selective knock-down of the sodium channel -subunit
Nav1.6a, but not Nav1.1la, occluded T4's acute effects. We also determined the spatial and
temporal distribution of a nongenomic T4 receptor, integrin V3. At 24 hours post fertilization
(hpf), immunofluorescent assays showed no specific integrin V3 immunoreactivity in wild-type
zebrafish embryos. However, by 48 hpf, embryos expressed integrin V3 in RBs and primary
motoneurons. Consistent with this temporal expression, T4 modulated RB INa at 48 but not 24 hpf.
We next tested whether T4 rapidly modulated INa of caudal primary motoneurons, which express
the receptor (V3) and target (Nav1.6a) of rapid T4 signaling. In response to T4, caudal primary
motoneurons rapidly increased sodium current peak amplitude 1.3-fold.
Conclusion: T4's nongenomic regulation of sodium current occurs in different neuronal subtypes,
requires the activity of specific phosphorylation pathways, and requires both integrin V3 and
Nav1.6a. Our in vivo analyses identify molecules required for T4's rapid regulation of voltage-gated
sodium current.
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Background
Although thyroid hormone deficiency results in severe
neurodevelopmental deficits [1], the underlying mecha-
nisms remain unclear. The traditional mechanism for thy-
roid hormone action involves conversion of secreted
thyroxine (T4) to triiodothyronine (T3) by deiodination
at the cellular level by target tissues. T3 then binds to intra-
cellular nuclear thyroid hormone receptors to modulate
transcription over a time course of hours to days [2,3].
However, deletion of nuclear thyroid hormone receptors
have little effect on development [4], suggesting that
either unliganded thyroid hormone nuclear receptors
mediate the consequences of hypothyroidism [5] or non-
nuclear thyroid hormone receptors remain functional.
Recent studies have shown that exogenously applied T3
and T4 can act through extranuclear plasma membrane
receptors on a timescale of minutes [6], providing a non-
genomic mechanism for thyroid hormone signaling apart
from traditional nuclear signaling. Bergh et al. [7] showed
that the integrin dimer V3 acts in vivo as a nongenomic
thyroid hormone receptor in the chick chorioallantoic
membrane and that T4-V3 binding regulates angiogen-
esis. In addition, they found that V3 displayed a higher
binding affinity for T4 over T3. The increased specificity
for T4 supports the view that T4 acts as more than a pro-
hormone to T3.
Integrins are present during nervous system development
[8] and regulate neuronal migration [9] and apoptosis
[10]. We previously reported that blockade of integrin
V3 reduced voltage-gated sodium current in Rohon-
Beard primary sensory neurons (RBs) [11]. Here, we focus
on the intracellular pathways that translate T4-V3 sign-
aling into modulation of sodium current (INa). Davis and
colleagues [7,12] demonstrated that T4 binding to
integrin  V3 activates the mitogen-activated protein
kinase (MAPK) extracellular regulated kinase (ERK1/2)
pathway. In addition, thyroid hormones can regulate
other second messenger pathways, including the MAPK
p38 isoform [13] and protein kinase C [14,15]. The can-
didate intracellular messengers of rapid thyroid hormone
signaling may regulate sodium channel function via phos-
phorylation.
One possible scenario is that the involved intracellular
kinases and phosphatases directly regulate the phosphor-
ylation state of a sodium channel. Consistent with this
possibility, phosphorylation of voltage gated sodium
channels by MAPK (p38) reduces INa amplitude by 50%
[16]. In the zebrafish embryo, MAPK (ERK1/2), MAPK
(p38), and protein phosphatase (PP) subtypes PP1 and
PP2A are all expressed in the spinal cord at 48 hours post-
fertilization (hpf) [17], allowing for pharmacological
assay of the effects of kinase and phosphatase inhibition
on RB INa and embryonic T4 signaling.
Regardless of whether phosphorylation directly targets
sodium channels, our data indicate that rapid T4 signaling
regulates sodium channel function. In RBs, two different
types of sodium channels, Nav1.1l and Nav1.6a, carry INa
[18]. The contribution of the two channel types to RB INa
changes during development, with Nav1.6a channels
accounting for a majority of RB current at 48 hpf. We pre-
viously found INa sensitivity to T4 at 48 hpf [11], raising
the possibility that T4 rapidly regulates Nav1.6a channels.
While Nav1.6a is the major contributor to RB INa, it is also
widely expressed in the nervous system and is of critical
importance to development [19]. T4 regulation of
Nav1.6a current would provide a mechanism for thyroid
hormone to serve as an important developmental regula-
tor of neural activity.
Here, we identify the signaling mechanisms and sodium
channels underlying nongenomic T4 activity in embry-
onic zebrafish neurons. We also define the temporal and
spatial expression pattern of the nongenomic T4 receptor,
integrin V3, in zebrafish embryos. Our results indicate
that neuronal cell types expressing both V3 and
Nav1.6a sodium channels respond rapidly to T4 with an
increase in INa amplitude.
Materials and methods
All experimental procedures were approved by the Animal
Care and Use Committee of the Center for Comparative
Medicine at the University of Colorado Denver – Ans-
chutz Medical Campus.
Animals
Zebrafish (Danio rerio) adults were bred according to
guidelines outlined in The Zebrafish Book [20]. Embryos
were incubated at 28.5°C in embryo medium (130 mM
NaCl, 0.5 mM KCl, 0.02 mM Na2HPO4, 0.04 mM
KH2PO4, 1.3 mM CaCl2, 1.0 mM MgSO4, 0.4 mM
NaH2CO3) and staged according to external morphology
[21].
Electrophysiology
Whole cell voltage clamp recordings were obtained from
zebrafish spinal cord RBs as previously described
[11,18,22]. Voltage clamp recordings from caudal pri-
mary motoneurons (CaPs) were obtained from the
Tg(hb9:GFP) line (gift of Drs Michael Fox and Joshua
Sanes, Harvard University, Cambridge, MA, USA) that
express green fluorescent protein (GFP) in motoneurons
[23]. Tg(hb9:GFP) zebrafish were immobilized in Ringer
solution (145 mM NaCl, 3 mM KCl, 1.8 mM CaCl2, and
10 mM HEPES, pH 7.2) containing 0.02% tricaine (Sigma
St Louis, Missouri, USA) and glued laterally to glass cover-Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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slips. Glass dissecting needles sufficed for removal of skin
and detachment of overlying muscle fibers. Muscle fibers
and secondary motoneurons were removed by a suction
pipette to expose primary motoneurons. Three properties
identified CaPs: GFP expression, cell body size (approxi-
mately 10 M diameter), and ventrally projecting axons
[24]. For initial experiments, we used a reduced extracel-
lular sodium bath solution (30 mM NaCl, 97 mM N-
methyl glucamine, 20 mM tetraethylammonium (TEA), 3
mM KCl, 2 mM CoCl2, and 10 mM HEPES) to reduce
potential series resistance voltage errors arising from large
INa amplitudes. However, some experimental manipula-
tions (for example, knockdown of sodium channel -sub-
units or phosphatase blockade) reduced INa amplitudes;
in these cases, we used a normal 125 mM extracellular
sodium concentration to increase INa amplitudes and the
sensitivity of our measurements. Glass electrodes (2.0 to
3.5 MÙ) were filled with solution containing 10 mM
NaCl, 135 mM CsCl, 10 mM EGTA, and 10 mM HEPES.
We subtracted passive leak currents and capacitive tran-
sients from recordings of voltage-gated sodium using a P/
8 protocol. Data were acquired using an Axopatch 200B
amplifier (Axon Instruments, Foster City, California,
USA) and analyzed with Clampfit8 (Axon Instruments)
and Origin software (OriginLab, Northampton, Massa-
chusetts, USA).
Data presentation
Results are presented as means ± standard errors. Statisti-
cal analysis was performed with Origin v7.0 software
(OriginLab). Statistical comparisons of means were per-
formed by one-way ANOVAs with Bonferroni corrections
for multiple comparisons.
Hormone and drug application
T4 (3,3',5,5'-tetraiodo-L-thyronine (thyroxine); Sigma)
was prepared as a 30 mM stock solution in dimethyl sul-
foxide (DMSO) that was diluted to final concentrations in
extracellular recording solution immediately before use.
Vehicle (DMSO) control experiments indicated that the
final concentration of DMSO (0.001%) had no effect on
INa amplitudes; therefore, control and vehicle control data
were pooled (Control/DMSO). Kinase and phosphatase
inhibitors were applied to neurons in semi-intact prepara-
tions of the zebrafish embryo after obtaining control
recordings prior to treatment. PD98059 (50 M; Sigma),
1 M SB203580 (Sigma), or okadaic acid (OA; 1 nM to 1
M; Sigma) was applied for 1 hour at room temperature
before obtaining post-treatment recordings. The drugs
remained in the bath during post-treatment recording.
Immunocytochemistry
Whole mount embryos (24 to 48 hpf) were processed for
immunocytochemistry as previously described [25]. The
primary antibody, mouse anti-human monoclonal
LM609 (Millipore, Billerica, MA, USA), was diluted 1:100.
Secondary antibody was applied overnight at 4°C (1:500;
goat anti-mouse conjugated to Alexa 568; Invitrogen-
Molecular Probes, Carlsbad, California, USA). Controls
consisted of experiments done with LM609 that had been
previously incubated with 50 g/ml human V3 (Milli-
pore). In some experiments, the Tg(isl3:GFP) line (gift of
Drs Andrew Pittman and Chi-Bin Chien, University of
Utah) expressing GFP in RBs or the Tg(hb9:GFP) line
expressing GFP in motoneurons were used. GFP expres-
sion was revealed using a rabbit anti-GFP antibody conju-
gated to Alexa 488 (1:400; Invitrogen). For analysis,
embryos were mounted in a 1% low melting point agar-
ose solution and imaged using a Zeiss Pascal Confocal
Microscope using 10× or 40× objectives and separate 488
and 568 laser lines. Fluorescent images were collected dig-
itally as z-stacks of 2 m slices. Data are presented as pro-
jections of 20 to 25 slices.
Morpholino knock-down
Antisense oligonucleotide morpholinos (MOs) targeting
sodium channels Nav1.6a (1.6 MO) and Nav1.1l (1.1
MO) were synthesized and prepared as previously
described [18]. Injection solutions contained the dye Fast
Green (1%) to report efficient delivery of the MO to ani-
mal cells. For each Nav1 MO, control MOs were synthe-
sized by introducing mismatches at five positions.
Embryos that had either Nav1.6a or Nav1.1l sodium chan-
nel subunit knock-down were created by injection of 2 to
3 hpf wild-type embryos with solution containing 0.3 mM
MO antisense oligonucleotide [18]. All MOs have been
used previously and tested by standard control experi-
ments [18,19,26].
Embryos that had Fast Green within the animal cell 15
minutes post-injection were transferred to a petri dish
containing embryo medium (130 mM NaCl, 0.5 mM KCl,
0.02 mM Na2HPO4, 0.04 mM KH2PO4, 1.3 mM CaCl2,
1.0 mM MgSO4, 0.4 mM NaH2CO3) and then raised at
28°C until 48 hpf. Embryos that were injected with the
1.6 MO or 1.1 MO and selected for recording are referred
to as Nav1.6a or Nav1.1l morphants, respectively.
Results
Blockade of either p38 MAPK or PP1 alters RB INa 
amplitude and occludes the rapid T4 effect
In other systems, rapid thyroid hormone signaling
involves intracellular signaling kinase pathways such as
MAPK (ERK1/2) and MAPK (p38) [7,12,13,27-29]. To
identify intracellular mediators of rapid T4 signaling in
RBs, we used a pharmacological approach. We inhibited
MAPK (ERK1/2) or MAPK (p38) signaling by using the
blockers PD98059 or SB203580, respectively. In addition,
because phosphatase effects oppose kinase action we used
OA to block serine/threonine phosphatases. At low OANeural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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concentrations we blocked PP2A (1 to 20 nM OA) and at
higher concentrations we blocked both PP2A and PP1 (1
M OA). After incubation of spinal cord preparations in
conditions of kinase or phosphatase blockade, we tested
for effects of kinase and phosphatase inhibitors on INa
amplitude, in the absence and presence of T4.
Control/DMSO cells displayed a INa peak amplitude of
1,665 ± 116 pA (n = 23; Figure 1D) and responded to
acute T4 application with a 39 ± 5% increase in amplitude
(n = 4; P < 0.05). To test for involvement of ERK1/2, we
used PD98059 (50 M), a specific inhibitor of the ERK 1/
2 pathway component MEK1 [30,31]. By itself, PD98059
did not significantly alter INa peak density (1,756 ± 217
pA; n = 16; P = 0.69) compared to control/DMSO (Figure
1D). Further, RBs exposed to PD98059 could still respond
to T4 by rapidly increasing INa amplitude (Figure 2A, C).
Compared to control/DMSO cells, however, PD98059-
treated cells showed a blunted response to T4 (Figure 2C).
Whereas the PD98059 results suggest that the ERK1/2
pathway may partially mediate the rapid effects of T4, the
data do not implicate ERK1/2 signaling in tonic regula-
tion of the number of available sodium channels. In con-
trast, nongenomic T4 signaling regulates both the rapid
response to T4 as well as the tonic levels of available
sodium channels in RBs [11]. Overall, the PD98059
results suggest minimal involvement of the ERK1/2 path-
way in T4 regulation of RB INa.
We next tested the contribution of the MAPK (p38) path-
way that mediates rapid thyroid hormone signaling trig-
gered by T3 [13] and regulates INa density [16]. In contrast
to blockade of the ERK1/2 pathway, pharmacological
inhibition of the p38 pathway increased tonic INa ampli-
tudes (in the absence of exogenous T4) 1.48-fold (2458 ±
134 pA; n = 14; P < 0.05, ANOVA) (Figure 1D). Moreover,
following SB203580 treatment, T4 no longer produced a
rapid increase in INa amplitude. In fact, after SB203580
treatment, T4 application led to a 22 ± 4% (n = 5) decrease
in RB INa amplitude (Figure 2A, C). Overall, the effects of
SB203580 support involvement of the p38 pathway in
regulation of both the resting levels of available RB
sodium channels as well as the rapid response of RB INa to
T4.
The SB203580 results suggest that T4 acts rapidly on RBs
by opposing ongoing MAPK p38 signaling either by
inhibiting the kinase or by activating relevant serine/thre-
onine phosphatases. Two serine/threonine phosphatases,
PP2A and PP1, are both ubiquitously expressed in the
zebrafish spinal cord at 48 hpf [17], a time when T4 rap-
idly regulates RB sodium current. To test for involvement
of PP2A or PP1, we incubated zebrafish spinal cords with
the serine/threonine phosphatase inhibitor OA prior to
recording INa from RBs. At concentrations of 1 to 20 nM,
OA specifically inhibits PP2A. However, 1 and 20 nM OA
did not significantly alter INa  peak amplitudes in the
absence of T4 (1,761 ± 179 pA (n = 6) and 1,798 ± 283 pA
(n = 11), respectively). In contrast, the IC50 for PP1 inhi-
bition by OA is much higher (approximately 0.5 M)
[32]. OA at 1 M produced a drastic 90% reduction in
resting RB INa peak amplitudes (169 ± 33 pA; n = 7; P <
0.00001, ANOVA; Figure 1D). Further, following 1 M
OA treatment, T4 no longer increased RB INa amplitude (-
6 ± 4% change; n = 7; P = 0.98 versus no T4 added; Figure
2A, C). Both the tonic reduction in INa peak amplitude and
the occlusion of rapid T4 effects under conditions of PP1
blockade support the view that PP1 activity modulates RB
INa amplitudes.
Rapid T4 effects require sodium channel -subunit 
Nav1.6a
We tested whether T4's rapid action on RB INa amplitude
targeted a specific voltage-gated sodium channel isotype.
RBs express two different sodium channel -subunit
genes,  scn1.1l  and  scn8aa, which code for the voltage-
gated sodium channel proteins Nav1.1l and Nav1.6a,
respectively [33]. Interestingly, the conductance carried by
the mammalian homologue of Nav1.6a is significantly
reduced by activation of MAPK p38 [16]. We knocked
down either Nav1.1l or Nav1.6a using MOs, as done pre-
viously for effective and selective elimination of specific
Nav1 proteins in the zebrafish embryo [18,19].
As found previously, knockdown of either Nav1.6a or
Nav1.1l -subunits led to decreased RB INa peak ampli-
tudes (Figure 3D) [18]. Further, injection of the control
Nav1.6a 5-missense MO did not significantly alter RB INa
peak density. We next tested whether knock-down of
either sodium channel subunit prevented T4's rapid mod-
ulation of RB INa by acute application of T4 to morphant
embryos. We found that T4 increased RB INa amplitude in
control morphants (45 ± 8%; P < 0.05 versus no hor-
mone) to a similar extent as in wild-type embryos (39 ±
5%) [11] (Figure 3A, E). However, in Nav1.6a morphants,
T4 application did not increase INa amplitudes (-16 ± 5%;
P < 0.05 versus control morphants), indicating that rapid
T4 action targets Nav1.6a channels.
In contrast, in Nav1.1l morphant embryos, T4 application
increased RB INa (63 ± 10%; P < 0.05 versus no hormone),
suggesting that T4 does not require Nav1.1l channels to
increase RB INa  density. In Nav1.1l morphants, the
increase in INa amplitude induced by T4 actually exceeded
that produced in controls (63 ± 10% versus 45 ± 8%; P <
0.05), presumably because Nav1.6a channels carry the
majority if not all of the remaining current [18]. The
effects of T4 on Nav1.6a and Nav1.1la morphants indicate
that rapid T4 signaling targets Nav1.6a sodium channels.Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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Figure 1
p38 and protein phosphatase 1 blockade altered tonic sodium current peak amplitudes. (A) INa was elicited by 
depolarizing voltage steps ranging between -70 and +70 mV in 125 mM extracellular sodium solution from a holding potential 
of -80 mV. Traces represent recordings obtained from a Rohon-Beard cell (RB) sensory neuron in a 50 hpf embryo. (B-D) To 
block relevant kinase pathways, we incubated the exposed zebrafish spinal cord preparation in the indicated inhibitors for 1 
hour prior to recording INa peak amplitudes. We blocked two separate kinase pathways, ERK1/2 and p38, with the inhibitors 
PD98059 and SB203580, respectively. In order to block protein phosphatase (PP) activity, we used two different okadaic acid 
(OA) concentrations that inhibit either PP2A only (1 to 20 nM), or both PP2A and PP1 (1 M). (B) After a 1 hour incubation in 
SB203580, RB INa peak amplitude increased. Conversely, 1 M OA decreased RB INa peak amplitude. (C) Average current-volt-
age (I-V) relationships for INa recorded after p38 and PP1 inhibition showed changes in INa amplitude without alteration of the 
reversal potential (Erev). p38 inhibition (n = 14) led to an increase in INa amplitude compared to controls (n = 23). In contrast, 
phosphatase inhibition with 1 M OA (n = 7) reduced INa compared to controls. Neither treatment affected Erev. (D) Peak INa 
amplitudes of cells exposed to the ERK1/2 inhibitor PD98059 (n = 16) did not significantly change INa peak amplitude compared 
to controls (n = 23). However, incubation of zebrafish embryos in the p38 inhibitor SB203580 (n = 14) significantly increased 
INa peak amplitude (P < 0.05; ANOVA). Inhibition of PP2A (1 and 20 nM OA; n = 6 and 11, respectively) did not significantly 
change peak INa amplitude compared to controls. However, 1 M OA (n = 7), which inhibits both PP2A and PP1, resulted in a 
significant reduction in INa peak amplitude (P < 0.05; ANOVA). Asterisks represent a p-value of < 0.05 and error bars represent 
standard errors.
p38 and protein phoshatase 1 blockade altered tonic sodium current peak amplitudesNeural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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Antagonists of nongenomic thyroid hormone signaling do 
not affect RB INa in Nav1.6a morphants
Antagonists of thyroid hormone (3,3',5,5'-tetraiodothy-
roacetic acid (tetrac)) or of the integrin V3 block rapid
T4 signaling in RBs [11]. We next tested whether the
effects of thyroid hormone antagonism or V3 blockade
targeted Nav1.6a-mediated current. We exposed Nav1.6a
morphants to the thyroid hormone analog tetrac, or the
V3 function blocking antibody LM609. To more readily
detect changes in RB INa amplitude in Nav1.6a morphants,
we raised the extracellular sodium concentration to 125
mM to increase INa amplitudes. We previously showed
Figure 2
Blockade of p38 or protein phosphatase 1 occluded T4-induced rapid increase in sodium current amplitude.
(A) The traces show typical Rohon-Beard cell (RB) INa recordings elicited by a -10 mV depolarizing voltage step before (black)
and after acute application of 30 nM T3 (green) or 30 nM T4 (red). The PD98059, SB203580, and okadaic acid (OA) treatment
groups present RB INa recorded after 1 hour drug incubation. (B) Changes in INa peak amplitude over 5 minutes for either
control, PD98059, SB203580, or OA showed that none of the treatments increased run-down of the current during the
recording period. (C) Acute application of 30 nM T3 (n = 5) did not alter RB INa compared to control cells unexposed to
acute hormone treatment. However, 30 nM T4 (n = 11) significantly increased peak INa amplitude over time in control RBs.
PD98059 treatment (n = 6) did not significantly affect T4's increase in peak INa amplitude compared to controls. However,
SB203580 (n = 5) or OA (n = 3) treatments prevented a rapid increase in INa amplitude (P < 0.05; ANOVA) in response to
acute T4 application. The data presented were acquired in the presence of 125 mM extracellular Na+. Asterisks represent a p-
value of < 0.05 and error bars represent standard errors.Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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that tetrac reduces RB INa amplitudes in wild-type embryos
[11]. However, in Nav1.6a morphants, tetrac did not sig-
nificantly change RB INa amplitudes compared to Nav1.6a
morphants unexposed to tetrac (Figure 3F). We had also
previously demonstrated that LM609 reduced RB INa
amplitudes by 46% in wild-type embryos [11]. In con-
trast, in Nav1.6a morphants, LM609 injection did not sig-
nificantly affect INa  peak amplitudes compared to
Rohon-Beard cells in Nav1.6a morphants did not show a rapid T4 response Figure 3
Rohon-Beard cells in Nav1.6a morphants did not show a rapid T4 response. (A-C) The representative traces show 
Rohon-Beard cell (RB) INa before (black) and 5 minutes after (red) acute T4 application. Embryos had been injected with either 
the 1.6 missense control morpholino (Ctl MO) (A), or MOs targeting sodium channels Nav1.1l (1.1 MO) or Nav1.6a (1.6 MO) 
(C). (D) Injection of 1.6 MO or 1.1 MO reduced RB INa peak amplitude compared to control. The reductions in INa peak ampli-
tudes were consistent with previously reported values for successful knockdown of either Nav1.6a or nav1.1la [18]. Injection 
of 5-missense control MO did not significantly alter INa peak amplitude. The data presented in (D) were recorded in the pres-
ence of 30 mM extracellular Na+. (E) Embryos injected with 5-missense MO or 1.1 MO showed significant increases in RB INa 
peak amplitude after 5 minutes of T4 application. In contrast, RBs in 1.6 morphant embryos did not show an increase in INa 
amplitude after T4 application. (F) Injection of 1.6 MO (n = 3) reduced peak INa amplitude in 125 mM extracellular recording 
solution compared to controls (n = 5; P < 0.05). In control embryos, thyroid hormone antagonism (tetrac) or V3 blockade 
(LM609) injection reduced INa amplitudes [11]. However, in 1.6 morphant embryos, neither LM609 (n = 5) nor tetrac (n = 9) 
altered INa amplitudes compared to 1.6 morphants unexposed to LM609 or tetrac (n = 3). Asterisks represent a p-value of < 
0.05 and error bars represent standard errors.Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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uninjected Nav1.6a morphants (Figure 3F). The lack of
effect of either tetrac or LM609 in Nav1.6a morphants fur-
ther supports that the rapid T4-integrin signaling pathway
specifically targets Nav1.6a channels.
Developmental regulation of V3 expression temporally 
restricts T4 signaling in RBs
Whether T4 induced increases in sodium current occur
throughout development or if T4 signaling begins at a
defined developmental stage is unknown. The above
results combined with our previous study [11] indicate
that in order to respond rapidly to T4 at 48 hpf, RBs
require integrin V3 and the Nav1.6a sodium channel -
subunit. We next determined whether V3 is present and
if RBs respond rapidly to T4 at earlier stages. We reasoned
that absence of integrin V3 would prevent T4 from rap-
idly modulating RB INa. Accordingly, we tested our predic-
tion by determining the spatial and temporal V3
expression pattern.
To determine when RBs express the plasma membrane T4
receptor, we performed immunocytochemistry using the
LM609 antibody that specifically detects the V3 dimer
[34]. As expected, at 48 hpf the LM609 antibody revealed
immunoreactivity in dorsal spinal cord cells (Figure 4A)
and cells in the ventral spinal cord. However, at 24 hpf, no
immunoreactivity was detected (Figure 4B). To test
whether immunoreactivity was specific for V3, we pre-
Zebrafish embryos expressed integrin V3 at 48 hpf but not at 24 hpf Figure 4
Zebrafish embryos expressed integrin V3 at 48 hpf but not at 24 hpf. (A) The 48-hpf zebrafish embryos were fixed 
and incubated with the LM609 antibody. LM609 immunoreactivity was revealed using a rhodamine-labeled fluorescent second-
ary antibody and preparations were examined using confocal imaging. At 48 hpf, LM609 immunoreactivity specifically labeled 
cells along the dorsal spinal cord (asterisks), the location of Rohon-Beard cells (RBs). LM609 also labeled cells in the ventral 
spinal cord (arrowheads), consistent with the location of motoneurons. (B) In contrast, 24-hpf embryos did not display LM609 
immunoreactivity, consistent with an absence of integrin V3 expression at 24 hpf. (C) Pre-incubation of LM609 with 50 g/
ml V3 protein blocked immunoreactivity in 48 hpf embryos, indicating that the labeling was specific for V3. (D) 
Tg(isl3:GFP) transgenic zebrafish embryos expressed green fluorescent protein (GFP) in RBs under control of the islet3 pro-
moter. (E) LM609 immunoreactivity was present in dorsal cells. (F) GFP and LM609 immunoreactivity colocalized in RB soma 
and axon tracts. Scale bars: 200 m (A-C); 20 m (D, E, F).Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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incubated LM609 with integrin V3 protein prior to
zebrafish application. We found pre-incubation of LM609
with V3 protein prevented detection of immunoreac-
tivity (Figure 4C), indicating specificity of immunostains
for V3.
LM609 immunoreactive cells localized to the dorsal spi-
nal cord where RBs reside. To identify LM609 immunore-
active cells as RBs, we used transgenic Tg(isl3:GFP)
embryos. In this line, the isl3 promoter drives GFP expres-
sion in RBs (A Pittmann and Chi-Bin Chien, personal
communication). In 48 hpf Tg(isl3:GFP) embryos (Figure
4D–F), LM609 immunoreactivity colocalized with GFP,
revealing V3 expression on RB bodies. This result is
consistent with rapid V3-dependent T4 signaling in 48
hpf RBs [11]. In contrast, at 24 hpf, zebrafish embryos did
not show specific LM609 immunolabeling in either the
dorsal or ventral spinal cord (Figure 4B). These data indi-
cate that V3 dimers appear on RBs after 24 hpf.
At 24 hpf, Nav1.6a underlies a portion of RB INa [18].
Nonetheless, according to our model, the lack of V3
expression on RBs at 24 hpf would prevent T4 from rap-
idly modulating RB INa To test this prediction, we acutely
applied 30 nM T4 to the spinal cords of 24 hpf embryos
and recorded RB INa. In contrast to results obtained from
48 hpf embryos [11], we found that T4 had no significant
effect on RB INa amplitude at 24 hpf (Figure 5A, B). These
results indicate that acute modulation of RB INa requires
V3.
T4 rapidly increases sodium current density in CaPs
As another test of the requirement for integrin V3,
MAPK p38/PP1, and the Nav1.6a sodium channel -sub-
unit for rapid T4 signaling, we sought to identify another
neuronal cell type that expressed these critical compo-
nents and test whether T4 could also rapidly modulate INa
amplitude. The intracellular messengers are ubiquitously
expressed in the zebrafish spinal cord [17], and several
ventral spinal cord neurons, including interneurons and
motoneurons, express Nav1.6a [19,33]. We detected
LM609 immunoreactivity in the ventral spinal cord (Fig-
ure 4A) and now determined the identity of these neurons
by using the Tg(hb9:GFP) line. In Tg(hb9:GFP) embryos,
motoneurons express GFP, allowing morphological
assessment of cell bodies and axonal projections [23]. At
48 hpf, a subset of GFP expressing cells in Tg(hb9:GFP)
embryos were also immunoreactive for LM609 (Figure
6A–C). In particular, ventral neurons with large diameter
cell bodies, a hallmark of primary motoneurons, were co-
positive for GFP and LM609 (Figure 6B, C).
At 48 hpf, the spinal cord contains three different types of
primary motoneurons [24]. One primary motoneuron,
CaP, expresses Nav1.6a at 48 hpf [19,33]. Because rapid T4
modulation of INa  targets Nav1.6a, co-expression of
Nav1.6a and integrin V3 raised the possibility that CaPs
might respond to T4 with a rapid increase in INa ampli-
tude. To test this possibility, we applied 30 nM T4 to CaP
motoneurons, identified in Tg(hb9:GFP) 48-hpf embryos
by cell body size and ventrally projecting axons, while
recording INa. In control CaP recordings, INa peak density
decreased over 5 minutes by 7 ± 2%. However, CaP INa
density significantly increased by 28 ± 8% (P < 0.005)
after acute T4 application (Figure 6D–F). These results
support our model that rapid regulation of INa density by
T4 requires V3 and targets Nav1.6a channels.
Discussion
Summary
Our results identify messengers and targets of a rapid thy-
roid hormone signaling pathway that functions in the
zebrafish embryonic nervous system. The T4 pathway rap-
idly induces increased sodium current amplitudes and
requires the sodium channel isotype Nav1.6a even though
neurons express several different sodium channel iso-
types. Moreover, the results suggest that the phosphoryla-
tion state of an involved protein, perhaps even the
targeted sodium channel isotype, determines sodium
channel activity.
Signaling pathway
We propose a model in which the phosphorylation status
of a particular protein or set of proteins regulates RB INa
amplitude, and T4 rapidly alters the phosphorylation sta-
tus of relevant protein(s). Further, the data suggest that
serine/threonine phosphorylation and dephosphoryla-
tion reduce and increase, respectively, RB INa amplitude.
To increase RB INa amplitude, T4 may rapidly activate PP1
and/or inhibit p38. Consistent with our findings, PP1
modulates INa amplitudes in rat striatal neurons [35],
which express Nav1.6 [36]. Schiffmann et al. [35] found
that PP1 blockade reduced rat striatal INa amplitudes, sim-
ilar to our results in zebrafish RBs.
Our data do not provide information about the identity of
the phosphorylated protein(s). One possibility is that T4
binding to V3 activates intracellular pathways that
directly phosphorylate sodium channel -subunits. In
ND7/23 cells transfected with mammalian Nav1.6
sodium channels, activation of p38 produces a decrease in
INa  [16]. Of particular relevance, biochemical analysis
demonstrated that p38 activity regulated phosphorylation
of a specific Nav1.6 serine, S553, revealing the Nav1.6
sodium channel as a direct p38 phosphorylation target
[16]. On this basis, the RB T4-V3 pathway may modu-
late INa by regulating the phosphorylation state of the con-
served serine residue in zebrafish Nav1.6a.Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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T4 did not affect Rohon-Beard cell sodium current amplitude at 24 hpf Figure 5
T4 did not affect Rohon-Beard cell sodium current amplitude at 24 hpf. (A) The 24 hpf zebrafish embryos were 
tested for the ability of Rohon-Beard cells (RBs) to respond rapidly to T4. INa peak amplitudes did not significantly change over 
5 minutes of T4 application. In the representative recording, INa was elicited by a depolarizing voltage step to -10 mV from a 
holding potential of -80 mV. (B) At 24 hpf, 30 nM T4 application did not significantly alter RB INa (n = 6) compared to controls 
(n = 4). In contrast, when V3 is expressed in the spinal cord at 48 hpf, T4 acutely increased RB INa (48 hpf data from [11]).
T4 increases sodium current in caudal primary motoneurons Figure 6
T4 increases sodium current in caudal primary motoneurons. (A-C) Tg(hb9:GFP) transgenic embryos were incu-
bated with the V3 antibody LM609. The 48-hpf Tg(hb9:GFP) transgenics displayed LM609 immunoreactivity in dorsal (aster-
isks) and ventral cells (arrowheads). The ventral immunoreactivity for LM609 colocalized with green fluorescent protein (GFP) 
in primary motoneurons (C, arrowheads). Images are oriented with dorsal neurons and ventral neurons in the upper left and 
lower right corners, respectively. Scale bar: 50 m. (D, E) Caudal primary motoneuron (CaP) INa was recorded for 5 minutes 
(+ Time) either in the absence (D) or presence of T4 (E). Each trace shows current in response to a -10 mV depolarizing stim-
ulus. (F) At 50 to 55 hpf, zebrafish CaPs showed rapid increases in INa amplitude in response to acute application of T4. The 30 
nM T4 application significantly increased CaP INa (n = 5; P < 0.01) compared to controls (n = 5).Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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One result that the model does not fully account for, how-
ever, is the large reduction in RB INa amplitude produced
by PP1 inhibition. We previously reported that either T4
or V3 blockade reduced INa by only 50%, yet 1 M OA
reduced RB INa by nearly 90%. This discrepancy could be
attributed to different degrees of PP1 inhibition by 1 M
OA versus T4/V3 blockade. The large decrease in INa
amplitude produced by 1 M OA could also reflect phos-
phorylation effects triggered by non-T4-dependent mech-
anisms. For example, protein kinases C and A also have
effects on Nav1.6 amplitude [37].
V3 acts as a T4 receptor in the nervous system
The important developmental roles of integrins as cell sur-
face adhesion proteins have been well studied [8]. Less-
well studied, however, is the potential role of integrins as
receptors for hormones. Because neurons and glia [38]
express V3, nongenomic T4 signaling via V3 may
play an important role in nervous system development.
Here, we focused on integrin's role as a plasma membrane
receptor for thyroid hormones that traditionally signal
through nuclear receptors. We focused on the integrin
dimer,  V3, a protein that is important for neuronal
migration and axon extension [39-41], and is expressed
on dorsal root ganglia [42,43]. The fact that RGD (Asp-
Gly-Arg) proteins block rapid T4 signaling mediated by
V3 [7] suggests that the hormone interacts with the
RGD recognition site [44]. Davis et al. suggested that, in
addition to V3, seven other RGD integrin dimers may
function as thyroid hormone receptors [28].
In addition to T4, the iodothyronine T3 binds to integrin
V3 and activates both ERK1/2 and phosphatidyl inosi-
tol 3-kinase [45]. If T3 interacts with RB V3 to activate
ERK1/2 and phosphatidyl inositol 3-kinase, our data indi-
cate that activation of these signaling pathways has no
effect on RB INa amplitude. Although we found that T3
does not affect RB INa, previous studies show T3 can
increase INa depending on cell type. For example, chronic
T3 application increases INa in cultured rat hippocampal
neurons [46], but not rat cortex in vitro. This result was
attributed to increased nuclear thyroid hormone receptor
expression in hippocampus versus cortex leading to differ-
ential genomic regulation of sodium channel expression.
Additionally, T3 rapidly increases INa in cultured myocytes
[47,48] through mechanisms that involve rises in intracel-
lular calcium [48] and protein kinase C [47]. Altogether,
both T4 and T3 nongenomic signaling result in a variety
of downstream consequences due to the diversity of sign-
aling mechanisms activated by plasma membrane thyroid
hormone receptors.
Implications of rapid T4 targeting of Nav1.6a and 
importance to the nervous system
During intrauterine stages, the human embryo requires
maternally provided thyroid hormone for normal devel-
opment [49-51]. However, the specific roles and underly-
ing mechanisms of thyroid hormone action during
embryogenesis are poorly understood. Thyroid hormone
signals nongenomically to regulate migration of neural
cells in the embryonic nervous system [52]. Our data indi-
cate that thyroid hormone, acting rapidly via a plasma
membrane receptor, shapes emerging properties of neuro-
nal excitability. Specifically, thyroid hormone rapidly
modulates neuronal sodium current by targeting the
Nav1.6a subunit. The implications for mammals are sub-
stantial because the mammalian homologue, Nav1.6,
shows widespread expression in both the central and
peripheral nervous systems [53,54] and is highly
expressed during embryonic stages [55]. Moreover,
Nav1.6a plays important developmental roles for sensory
neuron survival and motoneuron axon growth in
zebrafish [19,25]. Taken together, these findings indicate
that modulation of Nav1.6 current during embryonic
stages serves as a strategic way to regulate both structural
and functional development of the nervous system.
In the context of our results, periods of thyroid hormone
deprivation during development would decrease sodium
current in neurons expressing both V3 and Nav1.6,
leading to reduced excitability. Conversely, an excess of
thyroid hormone would increase sodium current and
potentially induce pathological hyperexcitability, associ-
ated with seizures and developmental abnormalities.
Interestingly, increased expression of Nav1.6 channels are
associated with epileptogenesis in mouse hippocampal
neurons through mechanisms of enhanced excitability
[56], and acute increases in T4 have been reported to
cause seizures in humans [57]. Also of note, mice without
the functional sodium channel gene SCN8A are some-
what resistant to seizures [58] and children with congeni-
tal hypothyroidism have a significantly reduced incidence
of febrile convulsions [59]. Whether thyroid hormone can
acutely influence seizure activity through V3-depend-
ent regulation of Nav1.6 in mammals warrants further
study. Altogether, T4 regulation of Nav1.6a current pro-
vides an important mechanism to influence neuronal
activity and development.
We focused on rapid T4 signaling in the embryonic nerv-
ous system. However, V3 and Nav1.6 are also present in
the adult nervous system, raising the possibility that T4
acutely regulates sodium current in adults. During adult
stages, Nav1.6 is the primary sodium channel isoform
expressed at nodes of Ranvier [53]. T4 induced modula-
tion of Nav1.6 mediated current would alter INa at nodes
of Ranvier and, therefore, regulate axonal conductance.Neural Development 2009, 4:20 http://www.neuraldevelopment.com/content/4/1/20
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The mechanism of thyroid hormone action on adult neu-
rons is unclear, yet alterations in Nav1.6 current could
result in deficits in sensory neuron axonal conductance
and could account for states of hyper- or hypo-reflexia
observed in hyper- or hypothyroid patients, respectively
[60,61]. Studies on T4-V3's activation of angiogenesis
and tumor cell proliferation also have clinical corollaries
in adults as hypothyroid states reduce tumor cell prolifer-
ation in gliomas [62].
Conclusion
Our results delineate a pathway for rapid T4 signaling that
is initiated by V3 as a T4 receptor, transduced intracel-
lularly by regulation of phosphorylation states, and tar-
gets the Nav1.6a sodium channel -subunit. Our
proposed pathway predicts that T4's rapid modulation of
sodium current requires expression of both V3 and
Nav1.6a on the responding cell. Our data agree with the
prediction in three ways. First, in RBs, T4 rapidly increased
sodium current amplitudes at 48 but not 24 hpf, consist-
ent with detection of V3 at 48 but not 24 hpf. Second,
upon knock-down of Nav1.6a protein, exogenously
applied T4 no longer led to a rapid increase in RB INa
amplitude. Third, another neuronal population, CaP,
which expresses both V3 and Nav1.6a, responded to T4
with a rapid increase in INa amplitude. Uncovering the sig-
naling pathways and relevant proteins involved in nong-
enomic T4 signaling contributes to our understanding of
how thyroid hormone regulates development and func-
tion of the nervous system.
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